Nutromics is a groundbreaking brand with a bold vision: to eliminate preventable deaths by providing timely molecular patient data. Their mission is to revolutionize healthcare by offering continuous diagnostic monitoring to save millions of lives. The current standard of care in clinical diagnostics falls short, as it relies on insufficient and delayed lab tests, leading to poor patient outcomes and high healthcare costs.

Nutromics has developed a world-first lab-on-a-patch technology that combines multiple DNA sensors with microneedles. This innovative diagnostic platform tracks multiple crucial targets in real-time, providing clinicians with personalized insights. Unlike traditional blood tests that only offer a single data point hours later, Nutromics' patch continuously monitors patients, empowering clinicians to make faster, more informed decisions.

The brand's initial focus is on vancomycin, a commonly used drug in hospitals. Nutromics' patch aims to optimize vancomycin dosing, which can be challenging due to its narrow therapeutic window and potential toxicity. By keeping patients in the therapeutic range, Nutromics' patch improves efficacy and minimizes toxic overdoses.

Nutromics is committed to ongoing research and development, with a strategic product pipeline that includes monitoring a wide range of drugs, proteins, and metabolites. With a team of experts and support from the medical community, Nutromics is at the forefront of transforming healthcare. Their innovative approach has garnered recognition through published and peer-reviewed scientific papers.

Headquartered in Melbourne, Australia, and San Diego, California, Nutromics is dedicated to making a significant impact in the healthcare system right now